ILUMYA Approved in U.S. for Adults With Active Psoriatic Arthritis
The IL-23 inhibitor is approved for healthcare provider-administered treatment.
Related stories
UK Regulator Opens Antitrust Probe Into Meta’s Publisher Content Use
The UK Competition and Markets Authority is investigating Meta over potential business terms that would let it collect publisher content for products including AI tools.
H impact | REGULATION | Oct 30, 2026, 11:43 AM UTC
Uganda warns boarding schools of sanctions over unlawful operations
Uganda’s Ministry of Education and Sports says it will act against boarding schools operating unlawfully, citing learner safety.
M impact | REGULATION | Oct 30, 2026, 09:06 AM UTC
Trump’s Tariffs Have Not Reduced the U.S. Trade Deficit, IW Says
The IW says Trump’s tariffs have not reduced the U.S. trade deficit.
M impact | REGULATION | Oct 30, 2026, 07:52 AM UTC
US Sanctions Rwanda Military Amid Stalled Congo Peace Talks
The US imposed sanctions on Rwanda’s military as an EU envoy and Uganda’s Museveni criticized stalled Congo peace talks.
M impact | REGULATION | Oct 30, 2026, 07:38 AM UTC
IW Report Says Trump's Tariffs Failed to Cut US Trade Deficit
A report by the German Economic Institute (IW) says U.S. tariffs did not reduce the trade deficit.
M impact | REGULATION | Oct 30, 2026, 07:01 AM UTC
US Offers Audi a Tariff on Imports, Insider Says
A source identified as an insider says the United States offered Audi a tariff on imports.
M impact | REGULATION | Oct 30, 2026, 05:25 AM UTC